@article{article, title  = {{Osilodrostat dose impact on efficacy/safety in Cushing's disease: large, pooled analysis of LINC 2, 3, and 4}},

 publisher = {{Oxford University Press (OUP)}},

 url = {{https://doi.org/10.1093/ejendo/lvaf207 }},

 year = {{2025}},

 month = {{10}},

 author = {{Fleseriu M and Pivonello R and Lacroix A and Biller BMK and Feelders R and Gadelha M and Bertherat J and Belaya Z and Piacentini A and Pedroncelli AM and Newell-Price J}},

 doi = {{10.1093/ejendo/lvaf207}},

 volume = {{193}},

 journal = {{European Journal of Endocrinology}},

 issue = {{5}},

 pages = {{606-617}},

 note = {{Accessed on 2025/11/05}}}